Latest Equities News

Green & Gold Minerals posted a $886,828 loss for FY2026 amid a transformative year marked by its ASX listing and expansion into base metals exploration with the Herberton acquisition.

Revolution Private Credit Income Trust (ASX: REV) posted a 6.25% net return for its inaugural period, outperforming its benchmark, and executed an on-market buy-back worth $23 million.

Kapstream Investment Trust (ASX:KIT) reported a $3.031 million profit and a 1.48% net return for its inaugural period ending June 2026, underperforming its benchmark but completing a 5% unit buy-back post-period.

Dubber Corporation Limited (ASX:DUB) posted a 17% revenue drop in FY26 to $35.1 million, mainly due to a major contract loss in Europe, but narrowed its net loss by 78% excluding impairments and achieved cash flow breakeven in H2.

Beonic Limited grew revenue by 5.2% to $23.3 million in FY26, halving its loss and achieving positive operating cash flow, underpinned by a landmark Moroccan airport contract and product innovation.

Clime Capital has reported an unaudited $13.4 million pre-tax profit for FY26, declared a September quarter dividend, and is considering a special dividend pending audit completion.

Industrial Minerals Ltd has finalised its takeover of Galleon Metals, adding a 205km² gold exploration portfolio in WA’s Eastern Goldfields. The company also announced key board appointments, including a new Managing Director with direct Laverton expertise.

Argo Global Listed Infrastructure (ASX: ALI) reported a robust FY2026 with total assets rising to $529 million and a record fully franked dividend of 10 cents per share. The portfolio outperformed benchmarks, driven by strong gains in electric utilities and midstream energy sectors amid AI-driven data centre demand.

Regal Investment Fund posted a standout FY2026 with a 17.32% net return, tripling operating profit to $117.9 million and continuing its on-market buy-back program.

Syntara Limited’s FY2026 results show a 7.9% revenue decline and a 13.6% increase in net loss amid significant clinical progress, including FDA backing for its lead drug amsulostat and a successful $8.8 million capital raise.

OM Holdings reversed a loss to report a US$26.3 million profit in 1H 2026, driven by a major asset disposal and improved product margins despite lower sales volumes.

Pengana Private Equity Trust (ASX: PE1) posted a 23.2% net return for FY2026, powered by a dramatic revaluation of SpaceX and strong gains across a diversified private equity portfolio.